| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 02/20/2013 | CN102934814A Horsemeat sausage |
| 02/20/2013 | CN102934807A Duck sausage |
| 02/20/2013 | CN102934806A Mutton sausage |
| 02/20/2013 | CN102934805A Mule meat sausage |
| 02/20/2013 | CN102934804A Rabbit meat sausage |
| 02/20/2013 | CN102934803A Health-care crocodile sausage |
| 02/20/2013 | CN102934802A Health-care peacock sausage |
| 02/20/2013 | CN102934801A Health-care deer sausage |
| 02/20/2013 | CN102934691A Healthcare camel milk |
| 02/20/2013 | CN102266299B Composition chewing tablets for a zinc gluconate compound and preparation method thereof |
| 02/20/2013 | CN102086197B Protoberberine derivative with insulin-sensitizing activity and application thereof |
| 02/20/2013 | CN102028711B Enzymatically synthesized triglyceride type fish oil soft capsules and preparation method thereof |
| 02/20/2013 | CN101874031B Sirtuin modulating imidazothiazole compounds |
| 02/20/2013 | CN101700265B Application of notoginseng and extract thereof in preparing medicament for curing and/or preventing diabetic microangiopathies |
| 02/20/2013 | CN101292020B A process for the removal of sterols and other compounds from glycerol oils |
| 02/20/2013 | CN101129418B Compound formulation containing collybia albuminosa and green mushroom bacterium |
| 02/19/2013 | US8378118 Pyrazole-based thyroid receptor compounds |
| 02/19/2013 | US8377968 N-piperidinyl acetamide derivatives as calcium channel blockers |
| 02/19/2013 | US8377950 Crystalline form of 5-[4-[[3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl]methoxy]benzyl]thiazolidine-2,4-dione potassium salt |
| 02/19/2013 | US8377916 Steroids as agonists for FXR |
| 02/19/2013 | US8377878 Therapies for chronic renal failure |
| 02/19/2013 | US8377875 Therapeutics based on tau/microtubule dynamics |
| 02/19/2013 | US8377865 Growth hormone releasing peptides |
| 02/19/2013 | US8377692 Process for the manufacturing of human mononuclear phagocytic leukocytes |
| 02/19/2013 | US8377483 Bioactivation of iron salt, especially an ferric ferrous salt, by adding a magnesium salt (MgCl2); useful as a medicine to treat diseases such as diabetes, freshness preservative agent, and animal and plant growth promoter |
| 02/19/2013 | US8377428 Low salt forms of polyallylamine |
| 02/19/2013 | CA2749656A1 Nutritional supplements for women desiring to become pregnant, and pregnant and nursing women |
| 02/19/2013 | CA2612587C Process for preparing amorphous rosuvastatin calcium free of impurities |
| 02/19/2013 | CA2566433C Therapeutic agent for bh4-responsive hyperphenylalaninemia |
| 02/19/2013 | CA2486187C Kinase inhibitors |
| 02/19/2013 | CA2480557C Cycloalkylcarboxyl derivatives that stimulate glucose utilization and methods of use |
| 02/19/2013 | CA2448382C Use of hepcidin as a regulator of iron homeostasis |
| 02/15/2013 | CA2826966A1 Composition for lowering blood lipid and elevating high-density lipoprotein and method for manufacturing the same |
| 02/15/2013 | CA2826965A1 Composition for lowering blood lipid and elevating high-density lipoprotein and method for manufacturing the same |
| 02/15/2013 | CA2748794A1 Composition for lowering blood lipid and elevating high-density lipoprotein and method for manufacturing the same |
| 02/14/2013 | WO2013022312A2 Pharmaceutical composition for preventing or treating diabetes or fatty liver containing a cyp4a inhibitor as an active ingredient |
| 02/14/2013 | WO2013022178A1 Composition for the prevention and treatment of obesity containing an active ingredient in the form of a fermented or unfermented lonicera japonica and aurantii nobilis pericarpium mixed herbal-preparation extract, and a use therefor |
| 02/14/2013 | WO2013022091A1 Therapeutic agent for autoimmune diseases comprising pd-1 agonist |
| 02/14/2013 | WO2013021891A1 Amino-acid-containing composition for enhancing recovery from muscle fatigue |
| 02/14/2013 | WO2013021377A1 Novel peptides, compositions comprising the same and uses thereof in methods for the treatment of metabolic, cardiac and immune-related disorders |
| 02/14/2013 | WO2013021302A1 Anti-oxidant herbal composition |
| 02/14/2013 | WO2013021138A2 Yeast flakes enriched with vitamin d2, compositions containing same, method for preparing same, uses thereof, and device for implementing the method |
| 02/14/2013 | WO2013021076A1 Grape extract, nutritional supplement comprising grape extract, and the use thereof as a functional ingredient |
| 02/14/2013 | WO2013020440A1 Amide derivate, and preparation method therefor, pharmaceutical composition and use thereof |
| 02/14/2013 | WO2013020372A1 Methods and reagents for preventing and curing insulin resistance and diabetes mellitus |
| 02/14/2013 | WO2012169798A3 Novel oxyntomodulin derivatives and pharmaceutical composition for treating obesity comprising the same |
| 02/14/2013 | WO2012116349A3 Novel cocrystals of ezetimibe |
| 02/14/2013 | US20130042334 Capping-Prone RNA Polymerase Enzymes and Their Applications |
| 02/14/2013 | US20130041040 Solid pharmaceutical composition for buccal administration of agomelatine |
| 02/14/2013 | US20130041028 Methods of using (1s,3s)-3-amino-4-difluoromethylenyl-1-cyclopentanoic acid |
| 02/14/2013 | US20130041007 Selective Androgen Receptor Modulators |
| 02/14/2013 | US20130041001 Valsartan derivatives carrying nitrogen oxide donors for the treatment of vascular and metabolic diseases |
| 02/14/2013 | US20130040992 Substituted 2, 6-Diamino-3, 5-Dicyano-4-Aryl-Pyridines And Their Use As Adenosine-Receptor-Selective Ligands |
| 02/14/2013 | US20130040991 Pharmaceutical composition comprising gemfibrozil and cyp2c8 and/or oatp substrate drug such as repaglinide |
| 02/14/2013 | US20130040990 SYNTHESIS OF DGJNAc FROM D-GLUCURONOLACTONE AND USE TO INHIBIT ALPHA-N-ACETYLGALACTOSAMINIDASES |
| 02/14/2013 | US20130040988 3-amino-pyridine derivatives for the treatment of metabolic disorders |
| 02/14/2013 | US20130040986 Modulators of Cystic Fibrosis Transmembrane Conductance Regulator |
| 02/14/2013 | US20130040982 Oral sustained release formulation of huperzine a |
| 02/14/2013 | US20130040981 Pyridylvinylpyrazoloquinolines as PAR1 inhibitors |
| 02/14/2013 | US20130040978 Spiro isoxazoline compounds as sstr5 antagonists |
| 02/14/2013 | US20130040976 Indazole inhibitors of the wnt signal pathway and therapeutic uses thereof |
| 02/14/2013 | US20130040971 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040968 Fat or oil composition |
| 02/14/2013 | US20130040957 Deuterium-Enriched Pyrimidine Compounds and Derivatives |
| 02/14/2013 | US20130040956 Process for the preparation of stable, crystalline (6s)-n(5)-methyl-5,6,7,8-tetrahydrofolic acid |
| 02/14/2013 | US20130040955 6-cycloalkyl-pyrazolopyrimidinones for the treatment of cns disorders |
| 02/14/2013 | US20130040944 Mglur4 allosteric potentiators, compositions, and methods of treating neurological dysfunction |
| 02/14/2013 | US20130040943 Tricyclic pyridyl-vinyl pyrroles as par1 inhibitors |
| 02/14/2013 | US20130040942 Salts of potassium atp channel openers and uses thereof |
| 02/14/2013 | US20130040940 Mercaptoamidine derivatives and methods of use |
| 02/14/2013 | US20130040936 1,4-oxazepines as bace1 and/or bace2 inhibitors |
| 02/14/2013 | US20130040933 Azaindoles as janus kinase inhibitors |
| 02/14/2013 | US20130040929 Novel prolylcarboxypeptidase inhibitors |
| 02/14/2013 | US20130040928 Nitrogen heterocycle derivatives, preparation thereof and application thereof in human therapeutics |
| 02/14/2013 | US20130040927 Cholesterol absorption inhibitor and omega 3 fatty acids for the reduction of cholesterol and for the prevention or reduction of cardiovascular, cardiac and vascular events |
| 02/14/2013 | US20130040916 Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses |
| 02/14/2013 | US20130040912 Piperazinotriazines as pi3k inhibitors for use in the treatment antiproliferative disorders |
| 02/14/2013 | US20130040910 Method of treating vitamin b12 deficiency |
| 02/14/2013 | US20130040908 Substitution derivatives of n6-benzyladenosine-5' -monophosphate, methods of preparation thereof, use thereof as medicaments, and therapeutic preparations containing these compounds |
| 02/14/2013 | US20130040902 Method for enhancing milk quantity and quality |
| 02/14/2013 | US20130040878 Pharmaceutical combination for use in the treatment of diabetes type 2 patients |
| 02/14/2013 | US20130040877 Long-acting y2 receptor agonists |
| 02/14/2013 | US20130040006 Extracts of Eleutherococcus SPP., Preparation Method Thereof and Use of the Same |
| 02/14/2013 | US20130040004 Plant extract for treating diabetes and process for making same |
| 02/14/2013 | US20130040002 Anti-oxidant herbal composition |
| 02/14/2013 | US20130039983 Process for the production of ralfinamide salts substantially free from impurities having genotoxic effects |
| 02/14/2013 | US20130039981 Quick Dissolving, Long Acting Zinc Therapeutic Formulations |
| 02/14/2013 | US20130039970 Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics |
| 02/14/2013 | US20130039966 Bone Semi-Permeable Device |
| 02/14/2013 | US20130039960 Compositions for reduction of side effects |
| 02/14/2013 | US20130039955 Orally Ingested Metabolic Enhancer in Oral Thin Film Container |
| 02/14/2013 | US20130039918 Pharmaceutical Composition Using Connective-tissue Growth Factor |
| 02/14/2013 | US20130039916 ENGINEERED ANTI-IL-23p19 ANTIBODIES |
| 02/14/2013 | US20130039906 PYRAZOLO[3,4-c]PYRIDINE COMPOUNDS AND METHODS OF USE |
| 02/14/2013 | US20130039901 Treatment of Pompe's Disease |
| 02/14/2013 | US20130039898 Compositions of prokaryotic phenylalanine ammonia-lyase variants and methods of using compositions thereof |
| 02/14/2013 | US20130039892 Adherent stromal cells derived from plancentas of multiple donors and uses thereof |
| 02/14/2013 | US20130039888 Products and methods for delivery of polynucleotides by adeno-associated virus for lysosomal storage disorders |
| 02/14/2013 | US20130039885 Leukotoxin e/d as a new anti-inflammatory agent and microbicide |
| 02/14/2013 | US20130039857 Methods of suppressing cancer, increasing weight loss and/or increasing insulin sensitivity |